As proof-of-concept demonstrations,this strategy is employed to design peptides for a variety of targetproteins, ranging from a tumor marker (alpha fetoprotein, AFP) totwo virus surface proteins (SARS-CoV-2 RBD and norovirus P-domain),with ultrahigh affinities in the nanomolar range. This evidence concerns the gene AFP and neoplasm.